Susquehanna Fundamental Investments, LLC Cardiff Oncology, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.01 - $7.58 $245,665 - $371,685	-49,035 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$6.65 - $10.04 $67,317 - $101,634	10,123 Added 26.02%	49,035 $326,000
Q1 2021 May 17, 2021	SELL	$9.1 - $19.57 $56,420 - $121,334	-6,200 Reduced 13.74%	38,912 $360,000
Q4 2020 Feb 16, 2021	BUY	$12.02 - $24.71 $74,524 - $153,202	6,200 Added 15.93%	45,112 $812,000
Q3 2020 Nov 16, 2020	BUY	$4.25 - $14.19 $165,376 - $552,161	38,912 New	38,912 $552,000

12.8M

823K

78K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $117M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.